Hematology/ Oncology and Stem Cell Therapy : Impact Factor & More
eISSN: 2589-0646pISSN: 1658-3876
Open AccessShare this on:
Aims and Scope of Hematology/ Oncology and Stem Cell Therapy
Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value. Less
Key Metrics
CiteScore 
3
SJR
Q3Oncology
SNIP
1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Hematology/ Oncology and Stem Cell Therapy
Hematology/ Oncology and Stem Cell Therapy Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Publication Time | 27 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | King Faisal Specialist Hospital & Research Centre |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 27 |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Hematology/ Oncology and Stem Cell Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hematology/ Oncology and Stem Cell Therapy
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Impact of TMPRSS6 gene polymorphism on iron overload among children with sickle cell disease.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Allogeneic hematopoietic cell transplantation as the standard of care for blastic plasmacytoid dendritic cell neoplasm in first complete remission.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Epidemiology and outcomes of hospitalized patients with lung cancer and acute respiratory failure: National inpatient database analysis.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Relevant biomarkers in acute graft-versus-host disease secondary to transplantation of hematopoietic stem cells.
- 1 Apr 2025
- Hematology/oncology and stem cell therapy
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Impact of TMPRSS6 gene polymorphism on iron overload among children with sickle cell disease.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Allogeneic hematopoietic cell transplantation as the standard of care for blastic plasmacytoid dendritic cell neoplasm in first complete remission.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Epidemiology and outcomes of hospitalized patients with lung cancer and acute respiratory failure: National inpatient database analysis.
- 12 Sep 2025
- Hematology/oncology and stem cell therapy
Relevant biomarkers in acute graft-versus-host disease secondary to transplantation of hematopoietic stem cells.
- 1 Apr 2025
- Hematology/oncology and stem cell therapy
FAQs on Hematology/ Oncology and Stem Cell Therapy
How many articles did Hematology/ Oncology and Stem Cell Therapy publish last year? 
What is the eISSN & pISSN for Hematology/ Oncology and Stem Cell Therapy?
What is Citescore for Hematology/ Oncology and Stem Cell Therapy?
What is SNIP score for Hematology/ Oncology and Stem Cell Therapy?
What is the SJR for Hematology/ Oncology and Stem Cell Therapy?
Who is the publisher of Hematology/ Oncology and Stem Cell Therapy?
